<DOC>
	<DOCNO>NCT02121834</DOCNO>
	<brief_summary>This multiple dose study LY3050258 healthy men postmenopausal woman . This study evaluate safety well body tolerate LY3050258 . It last approximately 14 week 2 week follow-up appointment last treatment study drug .</brief_summary>
	<brief_title>A Study LY3050258 Healthy Participants</brief_title>
	<detailed_description />
	<criteria>Healthy male healthy postmenopausal female , include Japanese participant Body mass index ( BMI ) 18 35 kilogram per square meter ( kg/m^2 ) , inclusive Abnormal sit blood pressure determine investigator Abnormality 12lead electrocardiogram ( ECG ) , opinion investigator , place participant unacceptable risk study participation Aspartate aminotransferase ( AST ) alkaline phosphatase ( ALT ) great 2 time upper limit normal ( ULN ) Skin condition opinion investigator make participant unsuitable study participation Current use statin within last 3 month prior dose Current use previous use anabolic steroid precede 6 month prior dose Use dehydroepiandrosterone , potential overthecounter steroidal supplement , nutritional product intend weightreduction and/or performanceenhancing effect within 21 day prior dose</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2015</verification_date>
</DOC>